Hosted on MSN11mon
Stoke stock soars 70% post-market on epilepsy drug dataStoke Therapeutics (NASDAQ:STOK) stock shot up 70% in post-market trading Monday after the company reported positive results from studies for its drug STK-001 in the treatment of children and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results